Demonstration of efficacy of ectoparasiticides - Scientific guideline
Demonstration of efficacy of ectoparasiticides - Scientific guideline
Demonstration of efficacy of ectoparasiticides - Scientific guideline
PDCO work plan 2026
Human medicines European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen), aripiprazole, Date of authorisation: 30/06/2015, Revision: 19, Status: Authorised
Ilona Reischl re-elected as chair of Committee for Advanced Therapies
Concept paper on the development of a guideline for using owner assessment as efficacy parameter
Owner assessment as efficacy parameter - Scientific guideline
Veterinary medicinal products controlling Varroa destructor parasitosis in bees - Scientific guideline
Draft guideline on veterinary medicinal products controlling Varroa destructor parasitosis in bees - Revision 2
Testing and evaluation of the efficacy of antiparasitic substances for the treatment and prevention of tick and flea infestations in dogs and cats - Scientific guideline
Draft guideline for the evaluation of efficacy of ectoparasiticides - general requirements